Search

everythinglearnresearchcommunity

for

Search:↓

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Alopecia areata causes patchy hair loss due to the immune system attacking hair follicles.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Alopecia areata may be linked to higher heart disease risk.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Children with alopecia areata often have low vitamin D, especially if they have darker skin, it's not summer, or they're not White.

Newspaper articles on alopecia are often inaccurate and sometimes mix up different types of hair loss.

PRP is an effective and safe treatment for alopecia areata.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Older male COVID-19 patients are more likely to experience hair loss.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

A 4-year-old girl with a rare lupus condition was successfully treated with oral corticosteroids, leading to full recovery and hair regrowth.

Stopping the use of a tight headband and using specific treatments led to partial hair regrowth.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.